Business Description

Bio-Rad Laboratories Inc. is a leading provider of life science research and clinical diagnostic products, founded in 1952 and headquartered in Hercules, California, United States. The company generates revenue through advanced laboratory instruments, reagents, and software sold to research institutions, hospitals, and biopharma companies. Under the leadership of CEO Norman H. Schwartz, Bio-Rad continues to drive innovation with flagship products including the GelDoc and Bio-Plex systems. With strategic investments in digital automation and next-generation diagnostics, the firm is well-positioned for sustained global growth.

Everything on Bio-Rad Laboratories Inc.

Revenue (FY2025) $2.58B
YoY growth +0.7%
Operating margin 1.8%
Direction Expanding
Gross margin 51.9%
Net margin 29.4%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Norman Schwartz — Chief Executive Officer and Chairman of the Board View full profile ↗ Jeffrey L. Edwards — Director View full profile ↗ Gregory K. Hinckley — Director (Lead Independent Director) View full profile ↗ Melinda Litherland — Director View full profile ↗ Arnold A. Pinkston — Director View full profile ↗ Allison Schwartz — Director; Vice President, Global Supply Chain Clinical Diagnostics Group Operations View full profile ↗ James Barry — Executive Vice President and President, Life Science Group View full profile ↗ Jonathan P. DiVincenzo — President and Chief Operating Officer View full profile ↗ Eva Anette Engelhardt — Executive Vice President and President, Clinical Diagnostics Group View full profile ↗ Courtney C. Enloe — Executive Vice President, General Counsel and Secretary View full profile ↗ Sedat Evran — Executive Vice President, Global Supply Chain View full profile ↗ Roop K. Lakkaraju — Executive Vice President, Chief Financial Officer View full profile ↗ Rajat Mehta — Executive Vice President, Global Commercial Operations View full profile ↗
Bio-Rad Laboratories acquires DiaMed Holding AG — Clinical Diagnostics · 2007 View full deal ↗ Bio-Rad Laboratories acquires Stilla Technologies — Life Science · 2025 View full deal ↗ Bio-Rad Laboratories acquires QuantaLife, Inc. — Life Science · 2011 View full deal ↗ Bio-Rad Laboratories acquires Curiosity Diagnostics sp. z o.o. — Clinical Diagnostics · 2022 View full deal ↗ Bio-Rad Laboratories acquires Dropworks, Inc. — Life Science · 2021 View full deal ↗ Bio-Rad Laboratories acquires Celsee, Inc. — Life Science · 2020 View full deal ↗ Bio-Rad Laboratories acquires RainDance Technologies, Inc. — Life Science · 2017 View full deal ↗ Bio-Rad Laboratories acquires AbD Serotec (division of MorphoSys AG) — Life Science · 2013 View full deal ↗ Bio-Rad Laboratories acquires GnuBIO, Inc. — Clinical Diagnostics · 2014 View full deal ↗ Bio-Rad Laboratories acquires Diagnostics businesses of Biotest AG — Clinical Diagnostics · 2010 View full deal ↗ Bio-Rad Laboratories acquires Propel Labs cell sorting system — Life Science · 2012 View full deal ↗ Bio-Rad Laboratories acquires DiaMed Benelux — Clinical Diagnostics · 2012 View full deal ↗

Share Repurchase Program

Total authorized
$1.0 billion (2023 Share Repurchase Program: $500 million authorized in July 2023, plus an additional $500 million authorized in July 2024)
Remaining (FY2025)
$284.6 million (as of December 31, 2025)
Latest FY repurchased
$295.5 million (payments for purchases of treasury stock, year ended December 31, 2025)

Named Competitors

Becton DickinsonDanaherMerck KGaAQiagen N.V.Thermo Fisher ScientificAbbott LaboratoriesbioMerieuxDiaSorinWerfenQuidelOrthoRocheSiemens HealthineersTosoh +1 more

Recent SEC Filings

2026-04-30 Reported quarterly results (+1 more) View filing ↗
2026-04-24 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-19 Regulation FD disclosure View filing ↗
2026-02-12 Reported quarterly results (+1 more) View filing ↗
2025-10-29 Reported quarterly results (+1 more) View filing ↗
2025-09-30 Regulation FD disclosure View filing ↗
2025-08-26 Regulation FD disclosure View filing ↗
2025-07-31 Reported quarterly results (+1 more) View filing ↗
2025-07-28 Leadership change (directors/officers) (+1 more) View filing ↗
2025-06-30 Other event View filing ↗
2025-05-01 Reported quarterly results View filing ↗
2025-04-25 Shareholder vote results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.